MX9803290A - Composiciones de la vacuna influenza. - Google Patents
Composiciones de la vacuna influenza.Info
- Publication number
- MX9803290A MX9803290A MX9803290A MX9803290A MX9803290A MX 9803290 A MX9803290 A MX 9803290A MX 9803290 A MX9803290 A MX 9803290A MX 9803290 A MX9803290 A MX 9803290A MX 9803290 A MX9803290 A MX 9803290A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine compositions
- influenza vaccine
- antigens
- container containing
- antigenic preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion proporciona una composicion de vacuna en la forma de un estuche que comprende un primer contenedor que contiene una preparacion antigénica que comprende un antígeno o antígenos de influenza; y un segundo contenedor que contiene una cantidad efectiva del auxiliar de un chitosan. La preparacion del antígeno en el primer contenedor de preferencia antígenos de influenza de haemagglutiina y neuraminidasa.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9522351.7A GB9522351D0 (en) | 1995-11-01 | 1995-11-01 | Vaccine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9803290A true MX9803290A (es) | 1998-09-30 |
Family
ID=10783215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9803290A MX9803290A (es) | 1995-11-01 | 1998-04-27 | Composiciones de la vacuna influenza. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6136606A (es) |
EP (1) | EP0859632B1 (es) |
JP (1) | JP4010462B2 (es) |
KR (1) | KR100555687B1 (es) |
CN (1) | CN1201396A (es) |
AT (1) | ATE214615T1 (es) |
AU (1) | AU7322796A (es) |
BR (1) | BR9611218A (es) |
CA (1) | CA2236538C (es) |
DE (1) | DE69620001T2 (es) |
DK (1) | DK0859632T3 (es) |
ES (1) | ES2174112T3 (es) |
GB (1) | GB9522351D0 (es) |
MX (1) | MX9803290A (es) |
NO (1) | NO323555B1 (es) |
NZ (1) | NZ320488A (es) |
PT (1) | PT859632E (es) |
WO (1) | WO1997016208A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9525083D0 (en) * | 1995-12-07 | 1996-02-07 | Danbiosyst Uk | Vaccine compositions |
GB9725084D0 (en) | 1997-11-28 | 1998-01-28 | Medeva Europ Ltd | Vaccine compositions |
GB9914412D0 (en) * | 1999-06-22 | 1999-08-18 | Worrall Eric E | Method for the preservation of viruses,bacteria and biomolecules |
US20020177614A1 (en) * | 2001-03-23 | 2002-11-28 | Merril Carl R. | Methods for treating nuerodegenerative diseases including alzheimer's |
CA2489019A1 (en) * | 2001-06-15 | 2002-12-27 | Nordic Vaccine Technology A/S | Therapeutical vaccination |
WO2003072016A2 (en) * | 2001-11-19 | 2003-09-04 | Becton, Dickinson And Company | Pharmaceutical compositions in particulate form |
WO2003086454A1 (en) * | 2002-04-18 | 2003-10-23 | Akzo Nobel N.V. | Antigen-loaded chitosan microparticles for oral vaccination |
US20040253211A1 (en) * | 2003-04-30 | 2004-12-16 | Nastech Pharmaceutical Company Inc. | Method for diagnosing and treating cancer |
US7588774B2 (en) * | 2003-05-12 | 2009-09-15 | Becton, Dickinson And Company | Molecules enhancing dermal delivery of influenza vaccines |
US20050123550A1 (en) * | 2003-05-12 | 2005-06-09 | Laurent Philippe E. | Molecules enhancing dermal delivery of influenza vaccines |
GB0315632D0 (en) | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
EP1708742A4 (en) * | 2003-12-05 | 2008-11-05 | Becton Dickinson Co | METHOD FOR IMPROVING THE IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND USEFUL LINKS THEREFOR |
US20050129679A1 (en) | 2003-12-15 | 2005-06-16 | Nastech Pharmaceutical Company Inc. | Method for opening tight junctions |
WO2006019183A1 (ja) * | 2004-08-18 | 2006-02-23 | The University Of Tokushima | 粘膜免疫、その感作剤を用いる粘膜ワクチン及び予防接種システム |
US20060121055A1 (en) * | 2004-12-06 | 2006-06-08 | Becton, Dickinson And Company, Inc. | Compositions with enhanced immunogenicity |
CN100425288C (zh) * | 2005-01-28 | 2008-10-15 | 北京金迪克生物技术研究所 | 鼻腔喷雾型流感病毒灭活疫苗及其制备方法 |
CA2552596A1 (en) * | 2005-08-09 | 2007-02-09 | Solvay Pharmaceuticals B.V. | Methods and systems for determining mid-value titers |
EP2530162A1 (en) * | 2006-05-05 | 2012-12-05 | Temasek Life Sciences Laboratory Limited | Biomolecule surface display and uses thereof |
MX2009009912A (es) | 2007-03-27 | 2010-01-18 | Sea Lane Biotechnologies Llc | Constructos y colecciones que comprenden secuencias de cadena ligera sustitutas de anticuerpos. |
WO2009121004A2 (en) | 2008-03-28 | 2009-10-01 | Sea Lane Biotechnologies, Llc | Neutralizing molecules to viral antigens |
AU2010249046A1 (en) | 2009-05-13 | 2011-12-01 | Sea Lane Biotechnologies, Llc | Neutralizing molecules to influenza viruses |
CA2767392C (en) | 2009-07-06 | 2017-03-14 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
US9907746B2 (en) | 2009-07-06 | 2018-03-06 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
EP2308506A1 (en) * | 2009-10-02 | 2011-04-13 | Mucosis B.V. | Adjuvanted intranasal vaccine formulations |
CA2840079C (en) | 2010-07-06 | 2018-07-03 | Variation Biotechnologies Inc. | Compositions and methods for treating influenza |
MX359103B (es) | 2011-01-13 | 2018-09-14 | Variation Biotechnologies Inc | Composiciones y sus usos en el tratamiento de infecciones virales. |
US20130323280A1 (en) | 2011-01-13 | 2013-12-05 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
EP2736928B1 (en) | 2011-07-28 | 2019-01-09 | i2 Pharmaceuticals, Inc. | Sur-binding proteins against erbb3 |
US20140328876A1 (en) | 2011-11-18 | 2014-11-06 | Variation Biotechnologies Inc. | Synthetic derivatives of mpl and uses thereof |
US9975956B2 (en) | 2011-12-22 | 2018-05-22 | I2 Pharmaceuticals, Inc. | Surrogate binding proteins which bind DR4 and/or DR5 |
WO2013104995A2 (en) | 2012-01-12 | 2013-07-18 | Variation Biotechnologies, Inc. | Compositions and methods for treating viral infections |
WO2013111012A2 (en) | 2012-01-27 | 2013-08-01 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57136528A (en) * | 1981-02-09 | 1982-08-23 | Hayashibara Biochem Lab Inc | Preparation of viral vaccine |
CA1261264A (en) * | 1984-11-29 | 1989-09-26 | Shigeo Suzuki | Immunopotentiating agents and method |
US5817753A (en) * | 1985-12-04 | 1998-10-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
GB8712176D0 (en) * | 1987-05-22 | 1987-06-24 | Cosmas Damian Ltd | Drug delivery system |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
GB8904370D0 (en) * | 1989-02-25 | 1989-04-12 | Cosmas Damian Ltd | Liquid delivery compositions |
ATE131042T1 (de) * | 1990-04-25 | 1995-12-15 | Hoechst Ag | Pharmakologische zubereitung, enthaltend polyelektrolytkomplexe in mikropartikulärer form und mindestens einen wirkstoff. |
US5169840A (en) * | 1991-03-27 | 1992-12-08 | Nobipols Forskningsstiftelse | Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation |
JP3109886B2 (ja) * | 1991-12-13 | 2000-11-20 | デンカ生研株式会社 | 経鼻接種用ワクチン |
GB9202464D0 (en) * | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
JPH06166635A (ja) * | 1992-06-18 | 1994-06-14 | San Five Kk | 免疫アジュバント |
GB9419979D0 (en) * | 1994-10-04 | 1994-11-16 | Medeva Holdings Bv | Vaccine compositions |
-
1995
- 1995-11-01 GB GBGB9522351.7A patent/GB9522351D0/en active Pending
-
1996
- 1996-11-01 NZ NZ320488A patent/NZ320488A/en not_active IP Right Cessation
- 1996-11-01 CN CN96198047A patent/CN1201396A/zh active Pending
- 1996-11-01 BR BR9611218A patent/BR9611218A/pt not_active IP Right Cessation
- 1996-11-01 AU AU73227/96A patent/AU7322796A/en not_active Abandoned
- 1996-11-01 US US09/066,340 patent/US6136606A/en not_active Expired - Lifetime
- 1996-11-01 PT PT96935149T patent/PT859632E/pt unknown
- 1996-11-01 ES ES96935149T patent/ES2174112T3/es not_active Expired - Lifetime
- 1996-11-01 EP EP96935149A patent/EP0859632B1/en not_active Expired - Lifetime
- 1996-11-01 AT AT96935149T patent/ATE214615T1/de active
- 1996-11-01 KR KR1019980703215A patent/KR100555687B1/ko not_active IP Right Cessation
- 1996-11-01 DE DE69620001T patent/DE69620001T2/de not_active Expired - Lifetime
- 1996-11-01 CA CA2236538A patent/CA2236538C/en not_active Expired - Fee Related
- 1996-11-01 DK DK96935149T patent/DK0859632T3/da active
- 1996-11-01 JP JP51716097A patent/JP4010462B2/ja not_active Expired - Fee Related
- 1996-11-01 WO PCT/GB1996/002680 patent/WO1997016208A1/en not_active Application Discontinuation
-
1998
- 1998-04-27 MX MX9803290A patent/MX9803290A/es active IP Right Grant
- 1998-04-30 NO NO19981963A patent/NO323555B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1997016208A1 (en) | 1997-05-09 |
EP0859632B1 (en) | 2002-03-20 |
ATE214615T1 (de) | 2002-04-15 |
CA2236538C (en) | 2011-05-10 |
AU7322796A (en) | 1997-05-22 |
NO981963L (no) | 1998-06-30 |
US6136606A (en) | 2000-10-24 |
EP0859632A1 (en) | 1998-08-26 |
CA2236538A1 (en) | 1997-05-09 |
DK0859632T3 (da) | 2002-06-03 |
NZ320488A (en) | 2001-03-30 |
PT859632E (pt) | 2002-09-30 |
KR100555687B1 (ko) | 2007-06-08 |
ES2174112T3 (es) | 2002-11-01 |
JPH11515023A (ja) | 1999-12-21 |
DE69620001T2 (de) | 2002-11-21 |
BR9611218A (pt) | 1999-05-25 |
KR19990067255A (ko) | 1999-08-16 |
GB9522351D0 (en) | 1996-01-03 |
DE69620001D1 (de) | 2002-04-25 |
NO323555B1 (no) | 2007-06-11 |
JP4010462B2 (ja) | 2007-11-21 |
NO981963D0 (no) | 1998-04-30 |
CN1201396A (zh) | 1998-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9803290A (es) | Composiciones de la vacuna influenza. | |
GB2322801B (en) | Vaccine compositions for intranasal administration comprising chitosan and use thereof | |
ES2140076T3 (es) | Vacunas que contienen una saponina y un esterol. | |
MX9702336A (es) | Composiciones de vacuna. | |
EP1955709A3 (en) | Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines | |
AU3847801A (en) | Proteosome influenza vaccine | |
AU4622693A (en) | Potentiation of immunogenic response | |
GEP20053444B (en) | Immunogenic Liposome Compositions | |
HK1025220A1 (en) | Novel saponin compositions and uses thereof | |
GB9018061D0 (en) | Compositions for vaccines | |
EP0721782A3 (en) | Influenza vaccine containing pertussis toxin | |
AU4537100A (en) | Adjuvant combinations for immunization composition and vaccines | |
BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
ECSP961731A (es) | Vacunas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights | ||
HC | Change of company name or juridical status |